Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial
Abstract Objective: Add‐on cannabidiol (CBD) significantly reduced seizures associated with Dravet syndrome (DS) in a randomized, double‐blind, placebo‐controlled trial: GWPCARE1…
